SCOPUS 정보 검색 플랫폼

Clinical and Experimental Dermatology

Volumn 22, Issue 6, 1997, Pages 297-299

Thalidomide-induced toxic pustuloderma

(3) Darvay, A a Basarab, T a Russell Jones, R a

a EALING HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; THALIDOMIDE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PRURIGO; SKIN BIOPSY; SKIN TOXICITY; TOPICAL DRUG ADMINISTRATION; TREATMENT FAILURE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DERMATITIS, EXFOLIATIVE; DRUG ERUPTIONS; FEMALE; HUMANS; PRURIGO; SKIN; THALIDOMIDE;

EID: 0031410099 PISSN: 03076938 EISSN: None Source Type: Journal
DOI: 10.1111/j.1365-2230.1997.tb01101.x Document Type: Article

Times cited : (13)

References (9)

1
- 0021739443
- Toxic pustuloderma: A new entity?
- Staughton RCD, Rowland-Payne CME, Harper JI, McMichen H. Toxic pustuloderma: a new entity? J Royal Soc Med 1984; 77 (suppl. 4): 6-8.
- (1984) J Royal Soc Med , vol.77 , Issue.4 SUPPL. , pp. 6-8
- Staughton, R.C.D.¹ Rowland-Payne, C.M.E.² Harper, J.I.³ McMichen, H.⁴

2
- 0027530505
- Allopurinol induced toxic pustuloderma
- Yu RCH, Chu AC. Allopurinol induced toxic pustuloderma. Br J Dermatol 1993; 128: 95-8.
- (1993) Br J Dermatol , vol.128 , pp. 95-98
- Yu, R.C.H.¹ Chu, A.C.²

3
- 0025360646
- Toxic pustuloderma: A self limiting eruption
- Rustin MHA, Robinson TWE, Dowd PM. Toxic pustuloderma: a self limiting eruption. Br J Dermatol 1990; 123: 119-24.
- (1990) Br J Dermatol , vol.123 , pp. 119-124
- Rustin, M.H.A.¹ Robinson, T.W.E.² Dowd, P.M.³

4
- 0029819891
- Toxic Pustuloderma associated with clemastine therapy
- Feind-Koopmans A, van der Valk PGM, Steijlen PM and van de Kerkhof PCM. Toxic Pustuloderma associated with clemastine therapy. Clin Exp Dermatol 1996; 21: 293-5.
- (1996) Clin Exp Dermatol , vol.21 , pp. 293-295
- Feind-Koopmans, A.¹ Van Der Valk, P.G.M.² Steijlen, P.M.³ Van De Kerkhof, P.C.M.⁴

5
- 0027316252
- Pustular drug eruptions: A histological spectrum
- Burrows NP, Russell Jones R. Pustular drug eruptions: a histological spectrum. Histopathology 1993; 22: 569-73.
- (1993) Histopathology , vol.22 , pp. 569-573
- Burrows, N.P.¹ Russell Jones, R.²

6
- 0029759297
- New roles for thalidomide
- Powell RJ. New roles for thalidomide. Br Med J 1996; 313: 377-8.
- (1996) Br Med J , vol.313 , pp. 377-378
- Powell, R.J.¹

7
- 0027230553
- Thalidomide exerts its inhibitory action on tumour necrosis factor alpha by enhancing mRNA degradation
- Moreira AL, Sampaio EP, Zmuidzinas S et al. Thalidomide exerts its inhibitory action on tumour necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-80.
- (1993) J Exp Med , vol.177 , pp. 1675-1680
- Moreira, A.L.¹ Sampaio, E.P.² Zmuidzinas, S.³

8
- 0029295913
- Thalidomide treatment reduces tumour necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis
- Tramontana JM, Utaipat U, Molloy A et al. Thalidomide treatment reduces tumour necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1995; 1: 384-97.
- (1995) Mol Med , vol.1 , pp. 384-397
- Tramontana, J.M.¹ Utaipat, U.² Molloy, A.³

9
- 0029899677
- Thalidomide in autoimmune conditions
- Gardener-Medwin JM. Thalidomide in autoimmune conditions. Expert Opinion an Investigational Drugs 1996; 5: 829-41.
- (1996) Expert Opinion an Investigational Drugs , vol.5 , pp. 829-841
- Gardener-Medwin, J.M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.